Qurient Therapeutics Enters CRADA with the National Cancer I…
Article Source : BusinessWire
Link : https://www.businesswire.com/news/home/20240521344307/en/Qurient-Therapeutics-Enters-CRADA-with-the-National-Cancer-Institute-to-Collaborate-on-a-Phase-12-Clinical-Study-of-Q901-in-Combination-with-TROP2-ADC
- Date
- 2024-05-21
- Author
- QURIENT